Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Pranlukast Hemihydrate

Known as: N-(4-Oxo-2-(1H-tetrazol-5-yl)-4H-1-benzopyran-8-yl)-p-(4-phenylbutoxy)benzamide Hemihydrate, SC-215745 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
The possibility of newly developed α-glycosylated naringin (Naringin-G) as a solubilizing agent was investigated against… Expand
2015
2015
The present study was carried out to develop an oral formulation of pranlukast hemihydrate with improved dissolution and oral… Expand
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
2013
2013
The purpose of the present investigation was to develop and evaluate a self-microemulsifying drug delivery system (SMEDDS) for… Expand
  • table 1
  • table 2
  • table 3
  • figure 1
  • table 4
2011
2011
The α-glucosyl hesperidin (Hsp-G)-induced improvement of both the dissolution and absorption properties of pranlukast hemihydrate… Expand
2007
2007
We prepared microparticles containing nanoparticles of water-insoluble pranlukast hemihydrate (PLH) using a 4-fluid nozzle spray… Expand